Chromium/biotin treatment of Type II diabetes

Details Chromium/biotin treatment of Type II diabetes Chromium/biotin treatment of Type II diabetes

1998-07-06

1999-07-27

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514387, A61K 31555, A61K 31415

Patent

active

059290668

ABSTRACT:
A method for treating Type II diabetes by administering to an affected individual a combination of chromic tripicolinate and biotin. The two compounds are administered orally or parenterally at in daily dosages which provide between 50 and 1,000 .mu.g of chromium and between 25 .mu.g and 200 mg biotin, the amounts of chromium and biotin being selected together to provide a greater than additive effect.

REFERENCES:
patent: 4315927 (1982-02-01), Evans
patent: 5087623 (1992-02-01), Boynton et al.
patent: 5789401 (1998-08-01), McCarty

Affiliated with

Also associated with

Rating

Chromium/biotin treatment of Type II diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromium/biotin treatment of Type II diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromium/biotin treatment of Type II diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-878917